BioXcel Therapeutics, Inc. (BTAI) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AMLX, APLS, DAWN, EFTR, ELEV and others.
BTAI has a market capitalization of $28.43M, compared to an average peer market cap of $3.1B. BTAI is notably smaller than its average peer.
